Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pcDNA-HDAC6-FLAG Citations (13)

Originally described in: The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress.
Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP Cell. 2003 Dec 12. 115(6):727-38.
PubMed Journal

Articles Citing pcDNA-HDAC6-FLAG

Articles
Class I and IIa HDACs Mediate HIF-1alpha Stability Through PHD2-Dependent Mechanism, While HDAC6, a Class IIb Member, Promotes HIF-1alpha Transcriptional Activity in Nucleus Pulposus Cells of the Intervertebral Disc. Schoepflin ZR, Shapiro IM, Risbud MV. J Bone Miner Res. 2016 Jun;31(6):1287-99. doi: 10.1002/jbmr.2787. Epub 2016 Mar 15. PubMed
Inhibition of HDAC6 Protein Enhances Bortezomib-induced Apoptosis in Head and Neck Squamous Cell Carcinoma (HNSCC) by Reducing Autophagy. Chang I, Wang CY. J Biol Chem. 2016 Aug 26;291(35):18199-209. doi: 10.1074/jbc.M116.717793. Epub 2016 Jul 1. PubMed
Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex. Salemi LM, Maitland MER, Yefet ER, Schild-Poulter C. BMC Cancer. 2017 Jul 1;17(1):460. doi: 10.1186/s12885-017-3430-2. PubMed
ARID1A-mutated ovarian cancers depend on HDAC6 activity. Bitler BG, Wu S, Park PH, Hai Y, Aird KM, Wang Y, Zhai Y, Kossenkov AV, Vara-Ailor A, Rauscher FJ III, Zou W, Speicher DW, Huntsman DG, Conejo-Garcia JR, Cho KR, Christianson DW, Zhang R. Nat Cell Biol. 2017 Aug;19(8):962-973. doi: 10.1038/ncb3582. Epub 2017 Jul 24. PubMed
A Novel Hydroxamate-Based Compound WMJ-J-09 Causes Head and Neck Squamous Cell Carcinoma Cell Death via LKB1-AMPK-p38MAPK-p63-Survivin Cascade. Yen CS, Choy CS, Huang WJ, Huang SW, Lai PY, Yu MC, Shiue C, Hsu YF, Hsu MJ. Front Pharmacol. 2018 Mar 1;9:167. doi: 10.3389/fphar.2018.00167. eCollection 2018. PubMed
Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation. Li W, Yue F, Dai Y, Shi B, Xu G, Jiang X, Zhou X, Pfeifer GP, Liu L. Cell Death Differ. 2018 Oct 12. pii: 10.1038/s41418-018-0211-7. doi: 10.1038/s41418-018-0211-7. PubMed
HDAC6 Regulates the MRTF-A/SRF Axis and Vascular Smooth Muscle Cell Plasticity. Zhang M, Urabe G, Little C, Wang B, Kent AM, Huang Y, Kent KC, Guo LW. JACC Basic Transl Sci. 2018 Dec 31;3(6):782-795. doi: 10.1016/j.jacbts.2018.08.010. eCollection 2018 Dec. PubMed
Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation. Hillert EK, Brnjic S, Zhang X, Mazurkiewicz M, Saei AA, Mofers A, Selvaraju K, Zubarev R, Linder S, D'Arcy P. Cancer Lett. 2019 Apr 28;448:70-83. doi: 10.1016/j.canlet.2019.02.003. Epub 2019 Feb 13. PubMed
A complex containing lysine-acetylated actin inhibits the formin INF2. A M, Fung TS, Kettenbach AN, Chakrabarti R, Higgs HN. Nat Cell Biol. 2019 May;21(5):592-602. doi: 10.1038/s41556-019-0307-4. Epub 2019 Apr 8. PubMed
Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine gamma-lyase protein degradation. Chi Z, Byeon HE, Seo E, Nguyen QT, Lee W, Jeong Y, Choi J, Pandey D, Berkowitz DE, Kim JH, Lee SY. Pharmacol Res. 2019 Aug;146:104281. doi: 10.1016/j.phrs.2019.104281. Epub 2019 May 21. PubMed
Honokiol ameliorates angiotensin II-induced hypertension and endothelial dysfunction by inhibiting HDAC6-mediated cystathionine gamma-lyase degradation. Chi Z, Le TPH, Lee SK, Guo E, Kim D, Lee S, Seo SY, Lee SY, Kim JH, Lee SY. J Cell Mol Med. 2020 Sep;24(18):10663-10676. doi: 10.1111/jcmm.15686. Epub 2020 Aug 4. PubMed
Silencing of Histone Deacetylase 6 Decreases Cellular Malignancy and Contributes to Primary Cilium Restoration, Epithelial-to-Mesenchymal Transition Reversion, and Autophagy Inhibition in Glioblastoma Cell Lines. Urdiciain A, Erausquin E, Zelaya MV, Zazpe I, Lanciego JL, Melendez B, Rey JA, Idoate MA, Riobo-Del Galdo NA, Castresana JS. Biology (Basel). 2021 May 26;10(6). pii: biology10060467. doi: 10.3390/biology10060467. PubMed
Deacetylation as a receptor-regulated direct activation switch for pannexin channels. Chiu YH, Medina CB, Doyle CA, Zhou M, Narahari AK, Sandilos JK, Gonye EC, Gao HY, Guo SY, Parlak M, Lorenz UM, Conrads TP, Desai BN, Ravichandran KS, Bayliss DA. Nat Commun. 2021 Jul 23;12(1):4482. doi: 10.1038/s41467-021-24825-y. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.